Original Article
A randomized, double-blind, parallel-group, single-dose comparative pharmacokinetic study of DRL_TZ, a candidate biosimilar of trastuzumab, with Herceptin® (EU) in healthy adult males
Volume 154 | Issue 3 | September 2021
Disclaimer:
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.